Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Huber

Showing results (21-30 of 752) with videos related to

Pageof 76
Sort By:
Hamostaseologie|February 5, 2014
[Translational medicine on the road to tailored therapies. 58. Annual Meeting of the Society of Thrombosis and Haemostasis e.V]Kurt Huber, Johann Wojta
Fundamental & Clinical Pharmacology|September 3, 2011
New anticoagulants for the prevention of stroke in atrial fibrillationThomas Höchtl, Kurt Huber
Wiener Klinische Wochenschrift|July 22, 2018
Changes and innovations of the 2017 ESC guidelines on dual antiplatelet therapy in coronary artery disease-a reviewHannes F Alber, Kurt Huber
European Heart Journal. Acute Cardiovascular Care|April 24, 2020
Cardiac Arrest in the COVID-19 EraChristian Hassager, Susanna Price, Kurt Huber
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 21, 2017
Bivalirudin in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: uncertainties almost clarifiedKurt Huber, Freek W A Verheugt
Vascular Pharmacology|January 17, 2012
Vascular effects of glycoprotein130 ligands--part II: biomarkers and therapeutic targetsSvitlana Demyanets, Kurt Huber, Johann Wojta
Nature Reviews. Drug Discovery|April 2, 2011
Fresh from the pipeline. TicagrelorKurt Huber, Bashar Hamad, Peter Kirkpatrick
Thrombosis and Haemostasis|January 5, 2023
Continuous Improvement of Antiplatelet Therapy in Cardiovascular DiseaseFreek W A Verheugt, Kurt Huber
Pathophysiology of Haemostasis and Thrombosis|February 5, 2005
New aspects in thrombotic research: complement induced switch in mast cells from a profibrinolytic to a prothrombotic phenotypeJohann Wojta, Kurt Huber, Peter Valent
JACC. Cardiovascular Interventions|February 9, 2019
Reply: Transfemoral Transcatheter Aortic Valve Replacement and On-Site Cardiac Surgery: More Than a Simple Debate About the Heart TeamFlorian Egger, David Zweiker, Kurt Huber
Pageof 76

Showing results (21-30 of 752) with videos related to

Sort By:
Pageof 76
Hamostaseologie|February 5, 2014
[Translational medicine on the road to tailored therapies. 58. Annual Meeting of the Society of Thrombosis and Haemostasis e.V]Kurt Huber, Johann Wojta
Fundamental & Clinical Pharmacology|September 3, 2011
New anticoagulants for the prevention of stroke in atrial fibrillationThomas Höchtl, Kurt Huber
Wiener Klinische Wochenschrift|July 22, 2018
Changes and innovations of the 2017 ESC guidelines on dual antiplatelet therapy in coronary artery disease-a reviewHannes F Alber, Kurt Huber
European Heart Journal. Acute Cardiovascular Care|April 24, 2020
Cardiac Arrest in the COVID-19 EraChristian Hassager, Susanna Price, Kurt Huber
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 21, 2017
Bivalirudin in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: uncertainties almost clarifiedKurt Huber, Freek W A Verheugt
Vascular Pharmacology|January 17, 2012
Vascular effects of glycoprotein130 ligands--part II: biomarkers and therapeutic targetsSvitlana Demyanets, Kurt Huber, Johann Wojta
Nature Reviews. Drug Discovery|April 2, 2011
Fresh from the pipeline. TicagrelorKurt Huber, Bashar Hamad, Peter Kirkpatrick
Thrombosis and Haemostasis|January 5, 2023
Continuous Improvement of Antiplatelet Therapy in Cardiovascular DiseaseFreek W A Verheugt, Kurt Huber
Pathophysiology of Haemostasis and Thrombosis|February 5, 2005
New aspects in thrombotic research: complement induced switch in mast cells from a profibrinolytic to a prothrombotic phenotypeJohann Wojta, Kurt Huber, Peter Valent
JACC. Cardiovascular Interventions|February 9, 2019
Reply: Transfemoral Transcatheter Aortic Valve Replacement and On-Site Cardiac Surgery: More Than a Simple Debate About the Heart TeamFlorian Egger, David Zweiker, Kurt Huber
Pageof 76